Friday, 26 May 2017

Generics News

  • Novartis case hearing against Indian patent office on Sept 11

    Generics |  News | By BioSpectrum Bureau | 0 Comment

    Bangalore: The Supreme Court will take up the landmark case involving swiss drugmaker Novartis and India's patent office on September 11, 2011. The case was due to come up for hearing on Au...Read more

  • Generics will lead to $7 bn loss for statins market

    Generics |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: GBI Research has highlighted that the introduction of generic statins has kick started a decline in the global statins market and this is expected to lead to a loss of over $7 bi...Read more

  • Sun Pharma's founder named India's 3rd richest

    Generics |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: For the first time, founder of leading Indian drugmaker Sun Pharmaceuticals, Mr Dilip Shanghvi has been named in the top three of India's richest men. Mr Shanghvi has made an ap...Read more

  • Mylan launches generic of Pfizer's antifungal drug

    Generics |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: US-based Mylan Pharmaceuticals has launched generic version of Pfizer's Vfend, Voriconazole for Oral Suspension, 40 mg/mL. Mylan was the first company to have filed a substantia...Read more

  • Cipla wins patent case against Roche

    Generics |  News | By BioSpectrum Bureau | 0 Comment

    Bangalore: India's generics giant Cipla has won a landmark patent case against Swiss drug maker Roche in the Delhi High Court. Roche had filed a patent infringement case against Cipla in 20...Read more

  • Sun Pharma registers Rs 1391 crores profit in Q1

    Generics |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: Posting a net profit of Rs 1391 crores in Q1, Sun Pharma exhibited a flat growth in line with the market expectations. India's most valued drug maker said that the process of acq...Read more

  • Teva patent request rejected by US Supreme Court

    Generics |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: The US Supreme Court declined a request from Teva Pharmaceutical for a stay of an appeals court ruling that would void patent protection for its $4 billion-a-year multiple sclero...Read more

  • Daiichi Sankyo seeks approval for TB drug in Japan

    Generics |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: Daiichi Sankyo's generic subsidiary, Daiichi Sankyo Espha has submitted a supplemental New Drug Application (sNDA) seeking approval for its synthetic broad-spectrum oral antibact...Read more

  • Aurobindo to acquire Actavis generics unit in EU

    Generics |  News | By BioSpectrum Bureau | 0 Comment

    Mumbai: India-based Aurobindo Pharma intends to acquire Actavis' generics commercial operations in seven markets in Western Europe. The transaction is conditional on certain antitrust appro...Read more

  • Ranbaxy sues Actavis to stop acne generic sale

    Generics |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: Dublin headquartered generic drugmaker Actavis has now been caught in a legal tangle after Indian drug major Ranbaxy Laboratories filed a legal case against the company. Ranbaxy...Read more

  • IPAB revokes patent for GSK's anti-cancer drug

    Generics |  News | By BioSpectrum Bureau | 0 Comment

    New Delhi: In yet another blow to multinational companies operating in India, the Intellectual Property Appellate Board (IPAB) has revoked the patent for UK drug maker GlaxoSmithKline's GSK...Read more

  • TWi appoints new CEO to boost US market

    Generics |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: Taiwan based TWi Pharmaceuticals has appointed Ms Tina Guilder as President and CEO and Ms Eva Ho as CFO to step up the US operation. TWi Pharmaceuticals announced that Ms Guild...Read more

  • German firm buys $200 mn stake in Indian generic company

    Generics |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: Gland Pharma, a leading Indian pure-play generic injectable pharmaceutical products company, has signed an agreement under which KKR, a global investment firm, will acquire a min...Read more

  • Biocon: A nesting ground for biotech spinoffs

    Generics |  Analysis | By BioSpectrum Bureau | 0 Comment

    It has added one more feather to its cap by being the nesting ground to churn out new start-ups. It is an informal incubation lab for new spinoffs. Biocon, without any hesitance, is the mo...Read more

  • FAPA: Indian pharma to fatten in biosimilars era

    Generics |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: The Federation of Asian Pharmaceuticals Association (FAPA) said that the upcoming patent cliff will be advantageous for the Indian drug makers as biosimilars are all set to make ...Read more

  • Celltrion files an FDA application for biosimilar

    Generics |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: With biosimilars promising an exponential growth, South Korea's Celltrion has filed an FDA application for Remisma, a biosilmilar of Johnson & Johnson's (J&J) blockbuster...Read more

  • Wockhardt's third Indian plant faces export ban

    Generics |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: Britain's drug regulator, the UK Medicines and Healthcare Products Regulatory Agency has revoked the quality compliance certificate provided to Wockhardt's third unit in India. ...Read more

  • Cipla appoints Subhanu Saxena as CEO

    Generics |  News | By BioSpectrum Bureau | 0 Comment

    Mumbai: Indian generic pharmaceuticals company Cipla appointed Mr Subhanu Saxena as its chief executive officer. Mr Saxena comes to Cipla with experience of over 25 years, having worked wit...Read more

Survey Box

Will biobanking change healthcare in the world?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls